Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
272 hedge funds and large institutions have $6.44B invested in Amicus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 88 increasing their positions, 99 reducing their positions, and 29 closing their positions.
72% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 29
64% more capital invested
Capital invested by funds: $3.92B → $6.44B (+$2.52B)
8% more funds holding
Funds holding: 251 → 272 (+21)
8% more call options, than puts
Call options by funds: $85.2M | Put options by funds: $79.1M
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0.33% less ownership
Funds ownership: 107.52% → 107.19% (-0.33%)
11% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 99
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$137M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$84.5M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$52M |
| 4 |
Morgan Stanley
New York
|
+$33.1M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$26.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$58.5M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$50.2M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$37.8M |
| 4 |
ClearBridge Investments
New York
|
-$27M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$24.9M |
FOLD Hedge Fund Activity: Q4 2020 in Review
272 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2020, worth a combined $6.44B — up 64% from $3.92B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new FOLD positions and 29 closed out — a net gain of 21 holders — while 88 added to existing stakes and 99 trimmed.
The largest buyer was Lone Pine Capital, opening a new position worth an estimated $137M. The largest seller was Janus Henderson Group, cutting an estimated $58.5M.
- 272 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2020, up from 251 in Q3 2020.
- Funds reported $6.44B of Amicus Therapeutics stock for Q4 2020, up 64% quarter-over-quarter.
- 50 funds opened new Amicus Therapeutics positions in Q4 2020 and 29 closed out, a net change of +21 holders.
- The largest Amicus Therapeutics buyer in Q4 2020 was Lone Pine Capital, an estimated $137M added.
- The largest Amicus Therapeutics seller in Q4 2020 was Janus Henderson Group, an estimated $58.5M sold.
Based on aggregated 13F filings for Q4 2020.